Like all cancers, early diagnosis presents the best chances of survival. Unfortunately,
lung cancer often remains undiagnosed until it's too late.
Therefore, a critical component of our strategy against lung cancer is exploring how diagnostic tools – tissue biopsy, liquid biopsy, immunoassay, and imaging technologies – can complement one another and ensure patients are presented with the best solutions at every stage.
cfRNA : 10~89 copies LoD
FFPE DNA : 1~2.5 % LoD
FFPE RNA : 10~89 copies LoD
RNA: ≥50ng
in less than 5 hours
πCode® MicroDisc is an innovative molecular analysis technology made of silicon wafers and have an extremely tiny size of 40μm in diameter. Each πCode® MicroDisc has an assigned distinct circular image pattern imprinted on its surface for multiplexing applications. A specific capture agent, which can be either nucleic acid probe or antibody, conjugated to its surface. πCode® MicroDiscs tagged with different capture agents are pooled, enabling specific detection of multiple analytes in one-well reaction.
